Combination of Lenvatinib and Pembrolizumab Is an Effective Treatment Option for Anaplastic and Poorly Differentiated Thyroid Carcinoma
乐伐替尼联合帕博利珠单抗是治疗未分化型和低分化型甲状腺癌的有效治疗方案
期刊:Thyroid
影响因子:6.7
doi:10.1089/thy.2020.0322
Dierks, Christine; Seufert, Jochen; Aumann, Konrad; Ruf, Juri; Klein, Claudius; Kiefer, Selina; Rassner, Michael; Boerries, Melanie; Zielke, Andreas; la Rosee, Paul; Meyer, Philipp Tobias; Kroiss, Matthias; Weißenberger, Christian; Schumacher, Tilmann; Metzger, Patrick; Weiss, Harald; Smaxwil, Constantin; Laubner, Katharina; Duyster, Justus; von Bubnoff, Nikolas; Miething, Cornelius; Thomusch, Oliver